ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 320

Evaluation of Anti-Citrullinated Type II Collagen and Anti-Citrullinated Vimentin Antibodies in Patients with Juvenile Idiopathic Arthritis

Brooke Gilliam1, Anil K. Chauhan2 and Terry L. Moore3, 1IM-Rheumatology, Saint Louis University, St. Louis, MO, 2Rheumatology, Saint Louis University, St. Louis, MO, 3Rheumatology/Immunology, Saint Louis University, St. Louis, MO

Meeting: ACR/ARHP Annual Meeting 2012

Keywords: Anti-CCP antibodies and juvenile idiopathic arthritis (JIA)

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Several studies have identified anti-cyclic citrullinated peptide (CCP) antibodies as an important indicator for destructive disease in patients with juvenile idiopathic arthritis (JIA). This is of particular significance in patients with IgM rheumatoid factor (RF)-positive polyarticular JIA, which closely resembles rheumatoid arthritis (RA). While the role of anti-CCP antibodies in RA and JIA is better understood, the identity of the target proteins of this modification remains undefined. We evaluated serum from patients with JIA to investigate the presence of anti-citrullinated type II collagen (CII) and anti-citrullinated vimentin antibodies, and their association with RF and anti-CCP antibody isotypes and previously measured anti-citrullinated fibrinogen and α-enolase antibodies. Our aim was to determine the prevalence and significance of previously identified target proteins for citrullination and elucidate their role in the disease process of JIA.

Methods:

Sera were obtained from 96 patients with various JIA subtypes, 19 systemic lupus erythematous (SLE) patients, and 10 healthy children. All sera were measured for antibodies against citrullinated and native CII and vimentin (vim1-16, vim59-74) by ELISA. Results were compared to anti-CCP antibody and RF isotypes, and our previously measured anti-citrullinated fibrinogen antibodies and anti-citrullinated α-enolase antibodies, in addition to erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).

Results: 

Mean levels of all anti-citrullinated antibodies were significantly higher in JIA patients than in healthy children (p<0.05). The most commonly detected citrullinated autoantibodies were anti-citrullinated CII (33.3%) and anti-citrullinated fibrinogen antibodies (32.3%), with the least commonly detected being anti-citrullinated α-enolase antibodies (9.4%). One IgM RF-positive polyarthritis patient was positive for all tested anti-citrullinated autoantibodies. The most common combination of positivity was anti-citrullinated CII and anti-citrullinated fibrinogen antibodies in 7 patients. Twenty-two subsets of patients were identified based on their anti-citrullinated autoantibody profile, not including anti-CCP antibody isotypes. Anti-citrullinated CII antibodies correlated significantly with all other citrullinated autoantibodies (p<0.05). Anti-citrullinated vimentin 1-16 and 59-74 demonstrated strong correlation with each other, and both correlated significantly with anti-citrullinated fibrinogen and alpha-enolase antibodies (p<0.05). Anti-citrullinated vimentin 1-16 antibodies also correlated with ESR (p<0.05). When including the group of citrullinated autoantibodies in logistic regression analysis, anti-citrullinated fibrinogen remained as the only autoantibody significantly correlated with joint damage (p<0.05).

Conclusion:

This study demonstrates that multiple citrullinated epitopes can be detected in JIA patients, especially those patients with polyarticular disease. Anti-citrullinated fibrinogen antibodies remained as the single citrullinated autoantibody to correlate significantly with joint damage.


Disclosure:

B. Gilliam,
None;

A. K. Chauhan,
None;

T. L. Moore,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2012

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-anti-citrullinated-type-ii-collagen-and-anti-citrullinated-vimentin-antibodies-in-patients-with-juvenile-idiopathic-arthritis/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology